The evolution and clinical impact of hepatitis B virus genome diversity

PA Revill, T Tu, HJ Netter, LKW Yuen… - Nature Reviews …, 2020 - nature.com
The global burden of hepatitis B virus (HBV) is enormous, with 257 million persons
chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists …

Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B

U Viswanathan, N Mani, Z Hu, H Ban, Y Du, J Hu… - Antiviral research, 2020 - Elsevier
The core (capsid) protein of hepatitis B virus (HBV) is the building block of nucleocapsids
where viral DNA reverse transcriptional replication takes place and mediates virus-host cell …

Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial

MF Yuen, K Agarwal, EJ Gane, C Schwabe… - The lancet …, 2020 - thelancet.com
Background Therapies with novel mechanisms of action against hepatitis B virus (HBV)
infection are being explored with the goal of achieving a functional cure (sustained off …

Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre …

MF Yuen, X Zhou, E Gane, C Schwabe… - The lancet …, 2021 - thelancet.com
Background RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator being
developed for the treatment of chronic HBV infection, was found to be safe and well tolerated …

[HTML][HTML] Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection

MS Sulkowski, K Agarwal, X Ma, TT Nguyen… - Journal of …, 2022 - Elsevier
Background & Aims Nucleos (t) ide reverse transcriptase inhibitors do not completely
suppress HBV DNA in chronic HBV infection (cHBV). Vebicorvir (VBR) is an investigational …

HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways

F Guo, Q Zhao, M Sheraz, J Cheng, Y Qi, Q Su… - PLoS …, 2017 - journals.plos.org
Hepatitis B virus (HBV) core protein assembles viral pre-genomic (pg) RNA and DNA
polymerase into nucleocapsids for reverse transcriptional DNA replication to take place …

Novel potent capsid assembly modulators regulate multiple steps of the hepatitis B virus life cycle

T Lahlali, JM Berke, K Vergauwen, A Foca… - Antimicrobial agents …, 2018 - Am Soc Microbiol
The assembly of hepatitis B virus (HBV) core protein (HBc) into capsids represents a critical
step of viral replication. HBc has multiple functions during the HBV life cycle, which makes it …

Novel Anti-Hepatitis B Virus Activity of Euphorbia schimperi and Its Quercetin and Kaempferol Derivatives

MK Parvez, S Ahmed, MS Al-Dosari… - ACS …, 2021 - ACS Publications
Natural or plant products, because of their structural diversity, are a potential source for
identifying new anti-hepatitis B virus (HBV) agents. Here, we report the anti-HBV activity of …

Preclinical profile and characterization of the hepatitis B virus core protein inhibitor ABI-H0731

Q Huang, D Cai, R Yan, L Li, Y Zong… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
ABSTRACT ABI-H0731, a first-generation hepatitis B virus (HBV) core protein inhibitor, has
demonstrated effective antiviral activity in chronic hepatitis B (CHB) patients in a phase 1b …

[HTML][HTML] Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves

MK Parvez, MS Al-Dosari, AH Arbab… - Saudi Pharmaceutical …, 2020 - Elsevier
Recently, we have shown in vitro anti-hepatitis B virus (HBV) activity of G. senegalensis JF
Gmel leaves, and Identified quercetin and other flavonoids by HPTLC. Here we report …